Journal of Shanghai Jiao Tong University (Medical Science) >

2024 , Vol. 44 >Issue 4: 469 - 473

DOI: https://doi.org/10.3969/j.issn.1674-8115.2024.04.007

Clinical research

Correlation analysis of serum miR-499 and severity of coronary lesions in patients with acute coronary syndrome

  • TANG Dongjuan ,
  • JIANG Lai ,
  • JIANG Ye
Expand
  • Department of Anesthesiology and SICU, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
JIANG Ye, E-mail: 722008524@shsmu.edu.cn.

Received date: 2023-09-18

  Accepted date: 2024-03-04

  Online published: 2024-04-28

Supported by

Key Clinical Project of Science and Technology Commission of Shanghai Municipality(17411954700)

Fold

Abstract

Objective ·To explore the value of miR-499 expression levels in the serum of patients with acute coronary syndrome (ACS) in predicting the severity of coronary artery disease. Methods ·Seventy-four patients with ACS admitted to Xinhua Hospital, Shanghai Jiao Tong University School of Medicine were included and divided into a mild group of 30 cases, a moderate group of 21 cases, and a severe group of 23 cases according to the Gensini score. Real-time quantitative polymerase chain reaction (qPCR) technology was used to detect the expression level of serum miR-499, while troponin (cTnI), creatine kinase isoenzyme (CK-MB), myoglobin (Mb), brain natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), and other laboratory indicators were measured. Spearman correlation analysis was used to analyze the correlation between the expression level of miR-499 and Gensini score, as well as the number of vessel branches in coronary artery disease. The evaluation value of miR-499 in assessing the severity of coronary artery disease was analyzed by using receiver operating characteristic (ROC) curve. Results ·The expression level of miR-499 increased with the severity of coronary artery disease (P=0.000). The expression level of miR-499 was positively correlated with Gensini score and cTnI (r=0.331, r=0.143, P<0.05), respectively, but not with LVEF (P>0.05), while Gensini score was not correlated with cTnI and LVEF (P>0.05). ROC analysis showed that the AUC of miR-499 for assessing the severity of coronary artery disease was 0.802 (95% CI 0.698?0.906), with sensitivity of 65.2% and specificity of 80.4%. The expression level of miR-499 increased with the increase of the number of coronary artery lesions, and was positively correlated with the number of coronary artery lesions (r=0.368, P<0.05). Conclusion ·The expression level of miR-499 in the serum of ACS patients is correlated with the severity and number of coronary artery lesions, which has a certain evaluation value in evaluating the severity of coronary artery lesions.

Key words： miR-499; acute coronary syndrome; biomarker; coronary artery stenosis

Cite this article

TANG Dongjuan , JIANG Lai , JIANG Ye . Correlation analysis of serum miR-499 and severity of coronary lesions in patients with acute coronary syndrome[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(4) : 469 -473 . DOI: 10.3969/j.issn.1674-8115.2024.04.007

References

1 WADA H, MIYAUCHI K, DAIDA H. Gender differences in the clinical features and outcomes of patients with coronary artery disease[J]. Expert Rev Cardiovasc Ther, 2019, 17(2): 127-133.
2 TONG K L, MAHMOOD ZUHDI A S, WAN AHMAD W A, et al. Circulating microRNAs in young patients with acute coronary syndrome[J]. Int J Mol Sci, 2018, 19(5): E1467.
3 GRüNTZIG A R, SENNING A, SIEGENTHALER W E. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty[J]. N Engl J Med, 1979, 301(2): 61-68.
4 GOELLER M, ACHENBACH S, CADET S, et al. Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease[J]. JAMA Cardiol, 2018, 3(9): 858-863.
5 WANG G K, ZHU J Q, ZHANG J T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans[J]. Eur Heart J, 2010, 31(6): 659-666.
6 LIU X, FAN Z, ZHAO T, et al. Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: an independent study of Han population[J]. Exp Gerontol, 2015, 72: 230-238.
7 CORSTEN M F, DENNERT R, JOCHEMS S, et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease[J]. Circ Cardiovasc Genet, 2010, 3(6): 499-506.
8 LI H Y, ZHAO X, LIU Y Z, et al. Plasma microRNA-126-5p is associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris[J]. Cell Physiol Biochem, 2016, 39(3): 837-846.
9 LI H, GAO F, WANG X, et al. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease[J]. Biosci Rep, 2019, 39(5): BSR20182016.
10 ZHU G F, YANG L X, GUO R W, et al. MicroRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score[J]. Coron Artery Dis, 2014, 25(4): 304-310.
11 中国医师协会急诊医师分会.2015中国急诊急性冠脉综合症临床实践指南(二): 诊断篇[J]. 中国急救医学, 2016, 36(1): 9-11.
11 Emergency Physician Branch of Chinese Medical Doctor Association. 2015 China emergency acute coronary syndrome clinical practice guidelines (Ⅱ): diagnosis section[J].Chinese Journal of Critical?Care?Medicine, 2016, 36(1): 9-11.
12 CHENG J, CHENG A, CLIFFORD B L, et al. MicroRNA-144 silencing protects against atherosclerosis in male, but not female mice[J]. Arterioscler Thromb Vasc Biol, 2020, 40(2): 412-425.
13 ARDERIU G, PE?A E, ALEDO R, et al. MicroRNA-145 regulates the differentiation of adipose stem cells toward microvascular endothelial cells and promotes angiogenesis[J]. Circ Res, 2019, 125(1): 74-89.
14 HE W, ZHU L, HUANG Y, et al. The relationship of microRNA-21 and plaque stability in acute coronary syndrome[J]. Medicine (Baltimore), 2019, 98(47): e18049.
15 WANG J, JIA Z, ZHANG C, et al. MiR-499 protects cardiomyocytes from H2O2-induced apoptosis via its effects on Pdcd4 and Pacs2[J]. RNA Biol, 2014, 11(4): 339-350.
16 REN J, ZHANG J, XU N, et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease[J]. PLoS One, 2013, 8(12): e80738.
17 ROMAINE S P, TOMASZEWSKI M, CONDORELLI G, et al. MicroRNAs in cardiovascular disease: an introduction for clinicians[J]. Heart, 2015, 101(12): 921-928.
18 AI J, ZHANG R, LI Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction[J]. Biochem Biophys Res Commun, 2010, 391(1): 73-77.
19 DEVAUX Y, VAUSORT M, GORETTI E, et al. Use of circulating microRNAs to diagnose acute myocardial infarction[J]. Clin Chem, 2012, 58(3): 559-567.
20 NEELAND I J, PATEL R S, ESHTEHARDI P, et al. Coronary angiographic scoring systems: an evaluation of their equivalence and validity[J]. Am Heart J, 2012, 164(4): 547-552.e1.
Options
Outlines

/

〈 〉